SCHEDULE 13G/AAccepted Feb 17, 4:34 PM ET
ArriVent BioPharma, Inc. SCHEDULE 13G/A
Accepted (ET)
4:34 PM
Feb 17, 2026
Filed
Feb 17, 2026
Documents
1
Size
9.5 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.